Enveric Biosciences, Inc. (ENVB): Total Liabilities
Older than the company's other figures. The latest Total Liabilities is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$4.00M
As of 2022-12-31
+27.7%
3-year compound annual growth
-34.3%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $4.00M | -9.5% | 2023-06-09, Balance as of period end |
| 2021-12-31 | $4.41M | +547.8% | 2023-06-09, Balance as of period end |
| 2020-12-31 | $681.2K | -64.5% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $1.92M | -89.8% | 2021-04-01, Balance as of period end |
| 2018-12-31 | $18.88M | -42.4% | 2020-08-12, Balance as of period end |
| 2017-12-31 | $32.75M | +17.6% | 2019-03-26, Balance as of period end |
| 2016-12-31 | $27.84M | +105.1% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $13.58M | n/a | 2017-04-04, Balance as of period end |